The advent and proliferation of targeted modalities represent an evolutionary leap forward in drug development. By binding ...
The "Equine Funeral Service Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Equine Funeral Service Market, valued at USD 198.35 million in 2025, is ...
The leaders of Chugai Pharmaceutical are tired of their company not getting its due. At the J.P. | The leaders of Chugai ...
Xtandi, Astellas’ roughly $6 billion prostate cancer juggernaut by annual sales, is set to lose U.S. patent protection in ...
The RNA therapy market presents opportunities in innovative RNA modalities, personalized medicine demand, and strategic ...
Microwave ablation plus chemotherapy significantly improves progression-free survival in advanced NSCLC without increasing toxicity compared to chemotherapy alone. The combination treatment leverages ...
Pipeline advances in 2026 span a range of dermatology disease areas, including atopic dermatitis, hidradenitis suppurativa, ...
The regulator’s Office of Prescription Drug Promotion (OPDP) has already sent out two letters alleging “false or misleading” ...
1h
Henlius Showcases "Globalisation 2.0" Strategy and Mid-to-Long-Term Innovation Blueprint at JPM 2026
The 44th J.P.Morgan Healthcare Conference (JPMHC) was successfully held in San Francisco, the United States, from January 12 ...
Andre Esteva, PhD, is an AI scientist, entrepreneur, and CEO of ArteraAI, revolutionizing cancer therapy through personalized diagnostics. A globally recognized ...
CBIC extends Duty Drawback, RoDTEP and RoSCTL benefits to exports via postal shipments from January 15, 2026, boosting MSME ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback